Project Grant R01DA064348
- This Project Grant award, funded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research on the "Addiction Potential, Flavoring Content, and Substitutability of Concept Flavored Cigarillos." The $752,701 award, with a performance period from August 1, 2025 to May 31, 2030, will be conducted by the University of Oklahoma Health Sciences Center (OUHSC). The research aims to investigate the addiction...
- The Project Grant award of $431,750 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a multi-method investigation of premium cigar use and marketing. The research aims to inform the regulation of cigar products, as premium cigars have experienced a resurgence in recent years but lack evidence on their public health impact and patterns of use, especially among young people. The project, to be conducted by Rutgers, The...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, has awarded a $718,374 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Nebraska Medical Center (UNMC). The 5-year grant, effective September 1, 2025, will support research to uncover how the co-exposure of nicotine exacerbates the adverse effects of antiretroviral drugs on placental development in pregnant women living with HIV-1. The study aims to employ...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $265,239 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of North Carolina at Chapel Hill (UNC-CH) to investigate the effects of vaping-induced oxidation on nicotine analogs in e-cigarettes. The project aims to evaluate the chemical composition of 6-methyl nicotine and nicotinamide vaping products before and after aerosolization, and assess...
- The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $654,500 Project Grant to the University of Tennessee Health Science Center in Tennessee. The grant, with a performance period from July 15, 2025 to March 31, 2030, will support research to investigate how social environment influences the hedonic value of nicotine and nicotine addiction. The project aims to study the role of the CACNA1C gene and the oxytocin receptor in...
- This $693,491 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a mixed methods study to advance the scientific understanding of nicotine pouch use among U.S. adults. The study will employ a nationally representative longitudinal survey integrated with qualitative interviews to investigate who is using nicotine pouches, their reasons for use, methods, frequency, and intensity of use, as well as...
- The U.S. National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $686,692 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Medical University of South Carolina. The grant will fund an 8-week clinical trial to assess the prospective changes in patient-reported and objective functioning following reduction of cannabis use among adults with cannabis use disorder. The trial will evaluate the benefits of cannabis harm...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $823,882 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Oregon Health & Science University (OHSU) on July 15, 2025. The TEAM-UP: Tobacco Treatment Navigators Uniting with Primary Care project aims to implement and compare two outreach strategies, a person-based Outreach Navigator (ON) and a technology-based Interactive Patient Portal (IPP), to improve...
- The National Institute on Drug Abuse (NIDA) has awarded a $159,139 Project Grant to George Washington University (GWU) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant, awarded on August 15, 2025, will support research on the "Impact of Derived Psychoactive Cannabis Product Marketing on Perceptions and Use Among Young Adults." This project aims to investigate the effects of the marketing and availability of cannabis products on usage patterns and...
- This federal Project Grant award of $385,638 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279). The purpose of the grant is to conduct research on the neurobehavioral consequences of chronic exposure to synthetic cannabinoids, also known as "synthetic marijuana", across different stages of lifespan development and between sexes. The research aims to elucidate the...
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $639,920 project grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Board of Regents of the Nevada System of Higher Education, operating through the University of Nevada, Reno. The grant, which runs from September 15, 2025 to May 31, 2030, will fund a human laboratory study to examine the influence of "natural" cigarillo descriptors on expectancies, subjective effects, smoking behavior, and exposure. The study aims to better understand how tobacco companies' use of "natural" claims for cigarillo products may impact perceptions of harm and influence use patterns, given the higher concentrations of toxins and carcinogens in cigarillo smoke compared to cigarettes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $639.9k | 8/29/25 |